http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-058617-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17 |
| filingDate | 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-058617-A1 |
| titleOfInvention | METHOD FOR THE TREATMENT OF PRIMARY AND SECONDARY FORMS OF GLAUCOMA |
| abstract | Methods and compositions for controlling ocular hypertension associated with (i) primary open angle glaucoma (POAG), (ii) other forms of glaucoma, or (iii) glucocorticoid therapy are described. The methods involve the administration of angiostatic agents and other IOP reducing agents (intraocular pressure) through local injections in the anterior segment of the eye. IOP reducing agents are among other angiostatic steroids, particularly anecortave acetate, and the preferred route of administration is an anterior juxtacle-scleral injection or implant. Anterior juxtacle scleral injections of anecortave acetate are able to control intraocular pressure for sustained periods of one to several months or more. This result is believed to be attributable to the facilitation of anecortave acetate access to the trabecular network by means of the anterior juxtaescleral administration route. This route of administration is also believed to be advantageous for other types of IOP reducing agents, particularly molecules that cannot easily penetrate the cornea due to size or other physical properties. |
| priorityDate | 2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID111332 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502635 |
Total number of triples: 10.